These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 36238563)
1. High-fat diet combined with dextran sulfate sodium failed to induce a more serious NASH phenotype than high-fat diet alone. Zhou Y; Feng Y; Yang L; Zheng P; Hang L; Jiang F; Yuan J; Zhu L Front Pharmacol; 2022; 13():1022172. PubMed ID: 36238563 [No Abstract] [Full Text] [Related]
2. Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction. Cheng C; Tan J; Qian W; Zhang L; Hou X Life Sci; 2018 Sep; 209():157-166. PubMed ID: 30096384 [TBL] [Abstract][Full Text] [Related]
3. Dextran Sulfate Sodium Salt-Induced Colitis Aggravates Gut Microbiota Dysbiosis and Liver Injury in Mice With Non-alcoholic Steatohepatitis. Shen B; Wang J; Guo Y; Gu T; Shen Z; Zhou C; Li B; Xu X; Li F; Zhang Q; Cai X; Dong H; Lu L Front Microbiol; 2021; 12():756299. PubMed ID: 34795650 [No Abstract] [Full Text] [Related]
4. DSS colitis promotes tumorigenesis and fibrogenesis in a choline-deficient high-fat diet-induced NASH mouse model. Achiwa K; Ishigami M; Ishizu Y; Kuzuya T; Honda T; Hayashi K; Hirooka Y; Katano Y; Goto H Biochem Biophys Res Commun; 2016 Jan; 470(1):15-21. PubMed ID: 26682925 [TBL] [Abstract][Full Text] [Related]
5. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis - Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogue. Daniels SJ; Leeming DJ; Detlefsen S; Bruun MF; Hjuler ST; Henriksen K; Hein P; Karsdal MA; Brockbank S; Cruwys S Biomed Pharmacother; 2019 Mar; 111():926-933. PubMed ID: 30841472 [TBL] [Abstract][Full Text] [Related]
6. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice]. Tian X; Xiong Q; Chen L; Wen JR; Ru Q Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123 [No Abstract] [Full Text] [Related]
7. Magnesium isoglycyrrhizinate attenuates nonalcoholic fatty liver disease by strengthening intestinal mucosal barrier. Lai X; Zhou H; Wan Y; Kuang J; Yang Y; Mai L; Chen Y; Liu B Int Immunopharmacol; 2024 Feb; 128():111429. PubMed ID: 38171057 [TBL] [Abstract][Full Text] [Related]
8. Jiang Zhi Granule protects immunological barrier of intestinal mucosa in rats with non-alcoholic steatohepatitis. Yu X; Zhang H; Pan J; Zou L; Tang L; Miao H; Zheng P; Xing L Pharm Biol; 2021 Dec; 59(1):1359-1368. PubMed ID: 34915801 [TBL] [Abstract][Full Text] [Related]
9. Metabonomics Application on Screening Serum Biomarkers of Golden Hamsters with Nonalcoholic Steatohepatitis Induced by High-Fat Diet. Hu J; Shen Y; Chen Y Comb Chem High Throughput Screen; 2023; 26(13):2280-2292. PubMed ID: 36815651 [TBL] [Abstract][Full Text] [Related]
10. Investigating the tamoxifen/high-fat diet synergy: a promising paradigm for nonalcoholic steatohepatitis induction in a rat model. Ezz-Eldin YM; Ewees MG; Azouz AA; Khalaf MM Naunyn Schmiedebergs Arch Pharmacol; 2024 Nov; 397(11):9067-9079. PubMed ID: 38884676 [TBL] [Abstract][Full Text] [Related]
11. BabaoDan attenuates high-fat diet-induced non-alcoholic fatty liver disease via activation of AMPK signaling. Sheng D; Zhao S; Gao L; Zheng H; Liu W; Hou J; Jin Y; Ye F; Zhao Q; Li R; Zhao N; Zhang L; Han Z; Wei L Cell Biosci; 2019; 9():77. PubMed ID: 31548878 [TBL] [Abstract][Full Text] [Related]
12. Metformin treatment reverses high fat diet- induced non-alcoholic fatty liver diseases and dyslipidemia by stimulating multiple antioxidant and anti-inflammatory pathways. Yasmin T; Rahman MM; Khan F; Kabir F; Nahar K; Lasker S; Islam MD; Hossain MM; Hasan R; Rana S; Alam MA Biochem Biophys Rep; 2021 Dec; 28():101168. PubMed ID: 34825068 [TBL] [Abstract][Full Text] [Related]
13. Hepatoprotective Effect of Bee Bread in Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) Rats: Impact on Oxidative Stress and Inflammation. Zakaria Z; Othman ZA; Suleiman JB; Che Jalil NA; Ghazali WSW; Nna VU; Mohamed M Antioxidants (Basel); 2021 Dec; 10(12):. PubMed ID: 34943134 [TBL] [Abstract][Full Text] [Related]
14. Phoenixin 14 Inhibits High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Experimental Mice. Yang F; Huang P; Shi L; Liu F; Tang A; Xu S Drug Des Devel Ther; 2020; 14():3865-3874. PubMed ID: 33061293 [TBL] [Abstract][Full Text] [Related]
15. [Effects of celastrol on autophagy and endoplasmic reticulum stress-mediated apoptosis in a mouse model of nonalcoholic fatty liver disease]. Tian T; Liao XC; Zhang M; Wu XM; Guo YT; Tan SY Zhonghua Gan Zang Bing Za Zhi; 2022 Jun; 30(6):656-662. PubMed ID: 36038329 [No Abstract] [Full Text] [Related]
16. Herp knockout protects against nonalcoholic fatty liver disease in mice on a high fat diet. Lei ZX; Wang JJ; Li K; Liu P Kaohsiung J Med Sci; 2021 Jun; 37(6):487-496. PubMed ID: 33464700 [TBL] [Abstract][Full Text] [Related]
17. Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. Mouries J; Brescia P; Silvestri A; Spadoni I; Sorribas M; Wiest R; Mileti E; Galbiati M; Invernizzi P; Adorini L; Penna G; Rescigno M J Hepatol; 2019 Dec; 71(6):1216-1228. PubMed ID: 31419514 [TBL] [Abstract][Full Text] [Related]
18. Pterostilbene Attenuates High-Fat Diet and Dextran Sulfate Sodium-Induced Colitis via Suppressing Inflammation and Intestinal Fibrosis in Mice. Fan-Jiang PY; Lee PS; Nagabhushanam K; Ho CT; Pan MH J Agric Food Chem; 2021 Jun; 69(25):7093-7103. PubMed ID: 34152136 [TBL] [Abstract][Full Text] [Related]
19. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism]. Zhong FW; Li GX; Zeng L Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697 [TBL] [Abstract][Full Text] [Related]
20. Colonic inflammation accelerates the progression of liver disease: A protective role of dipotassium glycyrrhizate. Fiaschini N; Negroni A; Palone F; Vitali R; Colantoni E; Laudadio I; Mancuso M; Cucchiara S; Stronati L Dig Liver Dis; 2022 Aug; 54(8):1084-1093. PubMed ID: 34903499 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]